“…Genetically targeted PS Killer Red (Bulina et al, 2006), MiniSOG (Ruiz-González et al, 2013), and SuperNova (Takemoto et al, 2013) have all been used to target intracellular organelles, with varying results on efficacy in directed cell killing, depending on the organelle targeted, expression level, and illumination parameters [reviews: (Wojtovich and Foster, 2014;Trewin et al, 2018)]. Targeted and activated photosensitizers (TAPs) using a genetically encoded fluorogen-activating protein (FAP) enable selective photosensitization directed to targeted cellular sites within genetically or molecularly targeted cells (Wang et al, 2017;Ackerman et al, 2019), as recently illustrated in transgenic zebrafish cardiovascular and nervous systems (He et al, 2016;Xie et al, 2020), and subcellular locations including mitochondria and telomeres, among others (Fouquerel et al, 2019;Jang et al, 2019;Qian et al, 2019). Due to the short range of action of 1 O 2 in living systems (Kuimova et al, 2009), this targeting and activation of the PS protects adjacent normal cells and reduces damage to nearby tissues, because photoactivity requires coincidence of the dye, the activating protein, and the illumination source (Lovell et al, 2010;He et al, 2016).…”